Mitroflow Aortic Bioprosthesis 5-Year Follow-Up: North American Prospective Multicenter Study Federico M. Asch, MD, David Heimansohn, MD, Daniel Doyle, MD, Walter Dembitsky, MD, Francis D. Ferdinand, MD, Jeffrey Swanson, MD, Joseph A. Dearani, MD, Neil J. Weissman, MD The Annals of Thoracic Surgery Volume 94, Issue 4, Pages 1198-1203 (October 2012) DOI: 10.1016/j.athoracsur.2012.04.090 Copyright © 2012 The Society of Thoracic Surgeons Terms and Conditions
Fig 1 Left ventricular (LV) mass regression 5 years after implantation of the Mitroflow valve. Plots (median, 25th, 75th percentiles, and range) by follow-up period (see Table 4). Solid line represents the regression estimate of LV mass across time. The Annals of Thoracic Surgery 2012 94, 1198-1203DOI: (10.1016/j.athoracsur.2012.04.090) Copyright © 2012 The Society of Thoracic Surgeons Terms and Conditions